Advertisement

Rational Development of Antigen-Specific Therapies for Type 1 Diabetes

  • Georgia Fousteri
  • Damien Bresson
  • Matthias Von Herrath
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 601)

Abstract

Administration of autoantigens, especially via the mucosal route, can induce tolerance under certain circumstances. In autoimmune diabetes, mucosal vaccination with autoantigens was frequently effective in restoring tolerance in mice but has not yet succeeded in humans. Furthermore, in some instances, autoimmunity can be precipitated upon autoantigen administration. We will here briefly discuss the underlying reasons and delineate which efforts should be made in the future to rationally translate antigen-specific immunotherapy, for example, by establishing better assays to reduce the risk for possible adverse events in humans.

Keywords

Major Histocompatibility Complex Class Oral Insulin Intranasal Insulin Fatal Anaphylaxis Mucosal Vaccination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arif, S., Tree, T.I., Astill, T.P., Tremble, J.M., Bishop, A.J., Dayan, C.M., Roep, B.O. and Peakman, M. (2004) Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113, 451–463.PubMedGoogle Scholar
  2. Bisikirska, B., Colgan, J., Luban, J., Bluestone, J.A. and Herold, K.C. (2005) TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115, 2904–2913.CrossRefPubMedGoogle Scholar
  3. Bresson, D., Togher, L., Rodrigo, E., Chen, Y., Bluestone, J.A., Herold, K.C. and von Herrath, M. (2006) Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116, 1371–1381.CrossRefPubMedGoogle Scholar
  4. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. and Weiner, H.L. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237–1240.CrossRefPubMedGoogle Scholar
  5. Cobbold, S. and Waldmann, H. (1998) Infectious tolerance. Curr. Opin. Immunol. 10, 518–524.CrossRefPubMedGoogle Scholar
  6. Dai, Y.D., Carayanniotis, G. and Sercarz, E. (2005) Antigen processing by autoreactive B cells promotes determinant spreading. Cell. Mol. Immunol. 2, 169–175.PubMedGoogle Scholar
  7. Faria, A.M. and Weiner, H.L. (2005) Oral tolerance. Immunol. Rev. 206, 232–259.CrossRefPubMedGoogle Scholar
  8. Harrison, L. and Hafler, D.A. (2000) Antigen-specific therapy for autoimmune disease. Curr. Opin. Immunol. 12, 704–711.CrossRefPubMedGoogle Scholar
  9. Harrison, L.C., Honeyman, M.C., Steele, C.E., Stone, N.L., Sarugeri, E., Bonifacio, E., Couper, J.J. and Colman, P.G. (2004) Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 27, 2348–2355.CrossRefPubMedGoogle Scholar
  10. Jasinski, J.M. and Eisenbarth, G.S. (2005) Hypothesis for the pathogenesis of type 1A diabetes. Drugs Today (Barc) 41, 141–149.Google Scholar
  11. Lernmark, A. and Agardh, C.D. (2005) Immunomodulation with human recombinant autoantigens. Trends Immunol. 26, 608–612.Google Scholar
  12. Liblau, R.S., Singer, S.M. and McDevitt, H.O. (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34–38.CrossRefPubMedGoogle Scholar
  13. Liu, E., Moriyama, H., Abiru, N., Miao, D., Yu, L., Taylor, R.M., Finkelman, F.D. and Eisenbarth, G.S. (2002) Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J. Clin. Invest. 110, 1021–1027.PubMedGoogle Scholar
  14. Mannering, S.I., Morris, J.S., Stone, N.L., Jensen, K.P., Van Endart, P.M. and Harrison, L.C. (2004) CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors. Ann. NY Acad. Sci. 1037, 16–21.CrossRefPubMedGoogle Scholar
  15. Melanitou, E., Devendra, D., Liu, E., Miao, D. and Eisenbarth, G.S. (2004)Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset. J. Immunol. 173, 6603–6610.PubMedGoogle Scholar
  16. Miller, J.F. (1995) Autoantigen-induced deletion of peripheral self-reactive T cells. Int. Rev. Immunol. 13, 107–114.CrossRefPubMedGoogle Scholar
  17. Mondino, A., Khoruts, A. and Jenkins, M.K. (1996) The anatomy of T cell activation and tolerance. Proc. Natl. Acad. Sci. USA 93, 2245–2252.CrossRefPubMedGoogle Scholar
  18. Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J.C., Elliott, J.F. and Eisenbarth, G.S. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220–223.CrossRefPubMedGoogle Scholar
  19. Ohashi, P.S. and DeFranco, A.L. (2002) Making and breaking tolerance. Curr. Opin. Immunol. 14, 744–759.CrossRefPubMedGoogle Scholar
  20. Oling, V., Marttila, J., Ilonen, J., Kwok, W.W., Nepom, G., Knip, M., Simell, O. and Reijonen, H. (2005) GAD65- and proinsulin-specific CD4+ T cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25, 235–243.CrossRefPubMedGoogle Scholar
  21. O’Shea, J.J., Ma, A. and Lipsky, P. (2002) Cytokines and autoimmunity. Nat. Rev. Immunol. 2, 37–45.CrossRefPubMedGoogle Scholar
  22. Ostroukhova, M., Seguin-Devaux, C., Oriss, T.B., Dixon-McCarthy, B., Yang, L., Ameredes, B.T., Corcoran, T.E. and Ray, A. (2004) Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114, 28–38.PubMedGoogle Scholar
  23. Roncarolo, M.G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28–50.CrossRefPubMedGoogle Scholar
  24. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164.PubMedGoogle Scholar
  25. Schwartz, R.H. (1996) Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184, 1–8.CrossRefPubMedGoogle Scholar
  26. Sherry, N.A., Tsai, E.B. and Herold, K.C. (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54, S32–S39.CrossRefPubMedGoogle Scholar
  27. Skyler, J.S., Krischer, J.P., Wolfsdorf, J., Cowie, C., Palmer, J.P., Greenbaum, C., Cuthbertson, D., Rafkin-Mervis, L.E., Chase, H.P. and Leschek, E. (2005) Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial—Type 1. Diabetes Care 28, 1068–1076.CrossRefPubMedGoogle Scholar
  28. Sosenko, J.M., Palmer, J.P., Greenbaum, C.J., Mahon, J., Cowie, C., Krischer, J.P., Chase, H. P., White, N.H., Buckingham, B., Herold, K.C., Cuthbertson, D. and Skyler, J.S. (2006) Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 29, 643–649.CrossRefPubMedGoogle Scholar
  29. Tian, J., Clare-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M., Mullen, Y., Sarvetnick, N., Tobin, A.J., Lehmann, P. and Kaufman, D. (1996) Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2, 1348–1353.CrossRefPubMedGoogle Scholar
  30. Tian, J., Gregori, S., Adorini, L. and Kaufman, D.L. (2001) The frequency of high avidity T cells determines the hierarchy of determinant spreading. J. Immunol. 166, 7144–7150.PubMedGoogle Scholar
  31. Weiner, H. L. (2001) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3, 947–954.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Georgia Fousteri
    • 1
  • Damien Bresson
    • 1
  • Matthias Von Herrath
    • 1
  1. 1.Department of Developmental ImmunologyLa Jolla Institute for Allergy and ImmunologyLa JollaUSA

Personalised recommendations